Hanseatic Management Services Inc Dynavax Technologies Corp Transaction History

Hanseatic Management Services Inc

  • $72.5 Million
  • Q4 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 29, 2022
SELL
$9.75 - $14.44 $292,363 - $432,997
-29,986 Closed
0 $0
Q4 2021

Feb 09, 2022
BUY
$13.17 - $20.94 $6,124 - $9,737
465 Added 1.58%
29,986 $422,000
Q3 2021

Oct 05, 2021
BUY
$9.16 - $19.83 $270,412 - $585,401
29,521 New
29,521 $567,000
Q1 2018

May 02, 2018
SELL
$14.65 - $19.9 $1,289 - $1,751
-88 Closed
0 $0
Q4 2017

Feb 14, 2018
SELL
$17.3 - $24.08 $830 - $1,155
-48 Reduced 35.29%
88 $2,000
Q3 2017

Nov 07, 2017
BUY
$15.2 - $21.5 $2,067 - $2,924
136
136 $3,000

Others Institutions Holding DVAX

# of Institutions
288
Shares Held
131M
Call Options Held
507K
Put Options Held
374K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.74B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Hanseatic Management Services Inc Portfolio

Follow Hanseatic Management Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hanseatic Management Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hanseatic Management Services Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email